1-Benzhydryl-2-methylazetidin-3-one

Catalog No. :
ACJCEI642
CAS No. :
959062-84-1
Molecular Formula :
C17H17NO
Molecular Weight :
251.33

IUPAC Name:1-benzhydryl-2-methylazetidin-3-one

1-Benzhydryl-2-methylazetidin-3-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$91.00Login to see priceIn stockInquiry
500mg95%$153.00Login to see priceIn stockInquiry
1g95%$229.00Login to see priceIn stockInquiry
5g95%$685.00Login to see priceIn stockInquiry
10g95%$1217.00Login to see priceIn stockInquiry
25g95%$2280.00Login to see priceIn stockInquiry
50g95%$3610.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Benzhydryl-2-methylazetidin-3-one
IUPAC Name1-benzhydryl-2-methylazetidin-3-one
MDL No.MFCD23106082
Molecular FormulaC17H17NO
Molecular Weight251.33
SMILESO=C1C(C)N(C(C2=CC=CC=C2)C3=CC=CC=C3)C1
InChI KeyNKWWUKVQOATGAN-UHFFFAOYSA-N
Synonym1-Diphenylmethyl-2-methyl-3-azetidone | 959062-84-1 | 1-benzhydryl-2-methylazetidin-3-one | 1-(DIPHENYLMETHYL)-2-METHYLAZETIDIN-3-ONE | 3-Azetidinone, 1-benzhydryl-2-methyl- | MFCD23106082 | AB86797 | PB38350 | SB20833 | 1-Benzhydryl-2-methyl-3-azetidinon
CAS No.959062-84-1
PubChem CID597376

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACJCEI642 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJCEI642 route product structure diagram
    ACJCEI642959062-84-1 In Stock
Inquiry

2. ACJCEI642 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJCEI642 route product structure diagram
    ACJCEI642959062-84-1 In Stock
Inquiry

Comments (0)